CLASS II Device recall · Reported 22 Jul 2020 · FDA Enforcement Report

MagNA Pure 96 Instrument, clinical sample concentrator recalled

Roche Molecular Systems is recalling MagNA Pure 96 Instrument, clinical sample concentrator, Material number 06541089001, distributed nationwide in the US. The recall was initiated on 3 Jun 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll units when used with Sample Transfer protocol version 3.0
Quantity recalled917

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2551-2020
FDA event ID
85838
Recalling firm
Roche Molecular Systems, Branchburg, NJ
Classification
Class II
Status
Terminated
Recall initiated
3 Jun 2020
FDA classified
10 Jul 2020
Reported
22 Jul 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

3 Jun 2020Recall initiated by company
10 Jul 2020Classified by FDA+37 days
22 Jul 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

When using Sample Transfer protocol version 3.0, the drop catcher is not activated on the MagNA Pure 96 instrument, which introduces a potential risk for cross-contamination leading to erroneous results.

Product as listed by the FDA

MagNA Pure 96 Instrument, clinical sample concentrator, Material number 06541089001 - Product Usage: This protocol is intended for pipetting samples into a MagNA Pure 96 Processing Cartridge (purification rack position 1) before a purification run.

Where it was distributed

Worldwide distribution - US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

When using Sample Transfer protocol version 3.0, the drop catcher is not activated on the MagNA Pure 96 instrument, which introduces a potential risk for cross-contamination leading to erroneous results.

Which lots are affected?

All units when used with Sample Transfer protocol version 3.0

Where was it sold?

Worldwide distribution - US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Molecular Systems

All 42

Other Other Medical Devices recalls

All 13,778